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ABSTRACT
We examine the interplay of the three major university actors in technology transfer from
universities to industry: the faculty, the technology transfer office (TTO), and the central
administration. We model the faculty as an agent of the administration, and the TTO as an agent of
both the faculty and the administration. Empirical tests of the theory are based on evidence from our
survey of 62 US research universities. We find that the TTOs reported licensing objectives are
influenced by their views of faculty and administration, which supports the assumption that the TTO
is a dual agent. The theory yields predictions for whether or not faculty disclose inventions and if
so, at what stage, which in turn affects license contract terms. We also examine how the portion of
inventions disclosed at different stages varies with faculty quality. Quality is found to be inversely
related to the share of license income allotted to faculty.
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In the more than two decades since the Bayh-Dole Act gave universities
the right to own and license inventions from federally funded research, the
number of technology transfer o±ces (TTOs) in U.S. universities has grown
from 25 to well over 200. These are the o±ces with primary responsibility
for implementation of the Bayh-Dole Act. While TTO objectives and or-
ganization vary across universities (see Bercovitz et al. (2001), Siegel et al.
(1999), and Thursby et al. (2001)), all TTOs are charged with facilitating
and managing thedisclosureand licensing of inventions with commercial po-
tential. In carrying out this mission, the TTO must balance the objectives
of the university, which owns the inventions, and the faculty, who create
them.1
In this paper, we present and test a model that allows us to examine
thisbalancing act and itse®ect on a critical element in the transfer process{
that is, whether or not inventions are disclosed by faculty, and if so, when.
In our recent survey of the TTOs of 62 U.S. universities, TTO directors
reported that educating and convincing faculty to disclose inventions is one
of their major problems.2 Many directors believethat substantially lessthan
half of theinventions with commercial potential are disclosed to their o±ce.
Faculty may not disclosefora variety of reasons ranging from not being able
to realizean invention hascommercial potential to not wanting to take time
away from their research. Many faculty may not want to get involved in
licensing because, as reported in the survey, faculty involvement in further
development (even after a license is executed) is necessary for commercial
success for 71% of the inventions licensed.
Not surprisingly, the directors we talked with believe that some of the
best inventionsmay not bedisclosed becausethemost productivefaculty are
less likely to want to take the timeto disclose inventions, much less work on
furtherdevelopment. Paradoxically, the directorswetalked with also believe
that many of the inventions disclosed to them are of questionable value.
Indeed, the director of a major university TTO described the TTO's job as
\the best we can do with the s**t we get to work with." This suggests that
the nature of inventions disclosed in U.S. universities is related to faculty
quality, and perhaps, in ways that are unexpected. While one might expect
higher quality faculty to produce higher quality inventions, and on average
1Thursby et al. (2001) report that, even for industry funded inventions, less than 5%
of the universities in the survey allow faculty ownership of inventions.
2As noted in Appendix A, questionnaires were sent to 135 universities for a 46 percent
response rate.
2they very likely do, it may well bethecase that a signi¯cant fraction of these
inventions are not disclosed to the TTO. Indeed, if high quality faculty
can obtain research funding without producing research with commercial
potential, oraresimply moreinterested in publication of theirresearch, then
one can argue that the fraction of inventions disclosed would be decreasing
in the quality of faculty inventors.
Given the importance of disclosure to the university technology transfer
process, we construct and analyze a game-theoretic model of this process
in which the central administration is the principal and both the TTO and
faculty are agents, but the need for disclosure implies the TTO is also an
agent for the faculty. The administration a®ects TTO and faculty incen-
tives by setting the shares of license income and sponsored research they
each receive. Theinventor's choice is whether to disclose, and if so, whether
to disclose the invention as soon as it is a proof of concept or to wait un-
til it is a lab-scale prototype. For inventions disclosed, the TTO chooses
whether or not to search for a licensee and determines the royalty income
and sponsored research in licenses executed. The administration, TTO, and
inventor are all expected utility maximizers, and we allow their utility to
depend on whether a license is executed, as well as licenseincome and spon-
sored research. Quality enters the model through its positive e®ect on the
probability that an invention is commercially successful.
The analysis yields predictions for contract terms as well as the stage
of development of inventions disclosed. In equilibrium, license income and
sponsored research are a function of quality, the licensee's cost of commer-
cialization, pro¯t fromsuccessful commercialization, and theshareof returns
that accrue to the TTO. Because of the e®ect of quality on the probability
of success, the TTO may include sponsored research in a license even if she
receives a zero share of these funds. In equilibrium, whether the inventor
discloses, and at what stage, is a function of the equilibrium license income
and sponsored research, the inventor's rate of time preference, and quality.
While, in general, comparativestaticresultsareambiguous, wepresent plau-
sible conditions under which higher quality faculty would disclose a higher
fraction of inventions at the proof of concept stage.
Empirical tests of the model provide support for the dual agency view
that TTOs measure their own success based on their perceptions of both
faculty and central administration objectives. Moreover, the more impor-
tant the TTO thinks an objective is to the two principals, the more she
pays attention to that objective as a measure of success. For example, our
survey results show that the TTO does not place as much weight on spon-
sored research as a license outcome as do faculty inventors or the central
3administration. Only 34 percent of TTOs thought it was extremely impor-
tant, while 48 percent of central administrationsand 75 percent of inventors
did. Nevertheless, our econometric results show that faculty and central
administration are a signi¯cant determinant of a TTO's view of sponsored
research, and that the TTOis more responsive to thefaculty's view of spon-
sored research. Furthermore, 71 percent of TTOs and 69 percent of central
administrations thought royalties were extremely important, but only 41
percent of inventors did. In this case our econometric results suggest that
the TTO pays more attention to the administration's view.
With respect to the stage of development, we ¯nd that universities with
higher academic rankings for their faculty have a higher proportion of dis-
closures licensed in the proof of concept stage. In the context of our theory,
this supports the view that the marginal impact of quality on the proba-
bility of success is highest at the proof of concept stage. We also ¯nd that
universities with higher fractions of inventions from medicine and nursing
or from engineering have a higher proportion of disclosures licensed in the
proof of concept stage. Although this might appear to be counterintuitive
for engineering, an applied science, this might simply be an indication of a
di®erence in attitudes towards commercialization. That is, engineering fac-
ulty may be more willing to participate in licensing, and thus more willing
to disclose early.3 In addition, it may well be the case that early stage in-
ventions in engineering have, in general, more obvious commercial potential
because the research in engineering, as in medicine and nursing, tends to
be more applied. Interestingly, we also ¯nd that universities with greater
net income have a smaller proportion of disclosures licensed in the proof of
concept stage. We believe this follows from \wealthier" TTOs discouraging
early stage inventions. However, as expected, more successful TTOs with
greaterincomeperlicenseencouragedisclosureat theproof of concept stage.
Finally, consistent with our assumption that administrations maximize
expected utility subject to participation constraints for the TTOs and in-
ventors, we ¯nd that the share of royalty income allotted to inventors is
lower for universities with higher quality faculty.
Theseresultscontributeto theburgeoning literatureon university-industry
technology transfer, which has tended to abstract from examining theroleof
the TTO in the process. Notable exceptions include Bercovitz et al. (2001)
and Siegel et al. (1999), who take an organizational perspective, and Hoppe
and Ozdenoren (2001), who focus on the TTO as an intermediary signal-
3See Louis et al (2001) and Owen-Smith and Powell (2001) for discussions of di®erent
perceptions across ¯elds regarding technology transfer.
4ing the quality of inventions to potential licensees. Thursby et al. (2001),
Thursby and Thursby (2001), and Jensen and Thursby (2001) discuss the
roleof TTOs in structuring license contracts to induce inventor cooperation
in further development after license execution. While they acknowledge the
balancing act played by the TTO, they abstract from the critical issue of
inducing faculty to disclose inventions. Finally, little work has been done
of the role of faculty quality in the process. In this regard, notable excep-
tions are Thursby, Jensen, and Thursby (2001), Thursby and Kemp (2002),
DeGregorio and Shane (2000), and Lach and Shankerman (2002).
2 A Theoretical Model of Disclosure and Licens-
ing
We choose to model the university licensing process as a game in which the
central administration of the university, A, is the principal, and both the
technology transfer o±ce (TTO), T, and the faculty inventor, I, are agents.
Essentially, the administration selects contract terms for both the TTO and
inventor, who then play a sequential move game of disclosure and licensing.
The basicunit of observation isa particular research project by theinventor
that yields a potential invention at the \proof of concept" stage of develop-
ment. As shown in Figure 1, at this stage the inventor has three choices.
He can: disclose this potential invention to the TTO; continue research to
develop the potential invention to the \lab-scaleprototype" stage; or switch
to another project.4 If he discloses, then the TTO can either search for
a potential partner/licensee or shelve the disclosure (i.e., return it to the
inventor). If he continues research, then when the potential invention is de-
veloped to the lab-scale prototype stage his choices are to disclose it to the
TTO or switch to another project. If he discloses, the TTO's choices are
to search for a partner or return the disclosure to the inventor. Note that,
although the additional research required to further develop the potential
invention involves a time cost and an e®ort cost, it also increases the prob-
ability of commercial success, and thus the probability the TTO can ¯nd a
partner and sell a license. Finally, when the inventor switches to another
4We abstract from a fourth possibility{that the inventor could attempt to commercial-
ize the invention herself rather than disclose it. Because universities are quite willing to
protect their propertyrights to facultyinventions, this choice would only be relevant if she
is willing to risk the inevitable legal consequences, as might be the case if the invention
has a high enough market value, or if she preceives the likelihood that the university can
successfully enforce its property rights is very low.
5project, he earns the (reservation) utility associated with it.
2.1 The TTO's Problem
To solvethisby backward induction, ¯rst considerthesubgamesbetween the
TTO and the potential licensee. We consider contracts of the form (R;S),
where R isthe present discounted valueof thestream of licenserevenuepaid
by the ¯rm, and S denotes funds provided to the university for sponsored
research. Sponsored research is paid at the time the license agreement is
signed, while royalties, which represent the bulk of license revenue, are not
paid unless and until theinvention is successfully commercialized.5 The¯rm
undoubtedly also bears somecosts associated with adopting and/or market-
ing the invention, which we denote by K: Let ¦ be the present discounted
value of the stream of pro¯ts resulting from the invention if it is a commer-
cial success. If p is the probability of success at the time the TTO searches
for a partner, then she can sell a license only if p(¦ ¡R) ¡S ¸ K. With
this formulation, we ignore all up-front license payments except those for
sponsored research, and we abstract from any output e®ects of royalties,
focusing instead on thecritical role of the probability of success.6 Notethat
the TTO cannot even give a license away, R = S = 0, unless theprobability
of commercial success is high enough, p ¸ K
¦.
There are two probability of success functions, depending on the stage
of development at the time of disclosure. If the invention is disclosed as
a proof of concept, then the probability of success is pC(S; Q), where Q is
an index of faculty quality. Several studies show the importance of faculty
involvement in furtherdevelopment if university inventions areto besuccess-
ful commercially (Agrawal and Henderson 2002, Jensen and Thursby 2001,
Thursby and Thursby 2002). Here we assume that sponsored research and
faculty quality both improve the probability that this e®ort will be success-
ful, so that pC(S; Q) is increasing at a decreasing rate in both arguments,
and is strictly concave. Similarly, if the invention is disclosed as a lab-scale
prototype, then the probability of success is pL(S; Q), which we also assume
is increasing at a decreasing rate in both arguments and is strictly concave.
We further assumethat 0 <pC(S; Q) <pL(S;Q) < 1, so there is some posi-
tiveprobability of success, even without further development, but success is
never a sure thing, and the probability of success, ceteris paribus, is always
5See Jensen and Thursby (2001) and Thursby, Jensen, and Thursby (2000) for the
prevalence of royalty contracts.
6See Jensen and Thursby (2001) for an analysis of the ine±ciency of royalty as com-
pared to equity contracts.
6greater for an invention at the lab-scale prototype stage than at the proof
of concept stage.
Weassumethat theTTOdirectormaximizesexpected utility. Herutility
is UT(yT;fT; `), whereyT is her licenseincome, fT is hersponsored research
funds, and ` is an indicator variable with ` = 1 if a license is executed and
` = 0 if not. As is standard among TTOs in the U.S., sponsored research
associated with a license is not considered as license income. Funds for
sponsored research are typically explicitly linked to continued development
by the inventor, and she may or may not be entitled to a share of those
funds. Moreover, as noted earlier, these funds are paid up-front, at the time
of licensing, while the bulk of license income comes from royalties which are
paid only if the invention succeeds. Naturally we assume positive but di-
minishing marginal utility from license income and sponsored research, and
positive marginal utility from execution of a license. Without loss of gener-
ality, we assume UT(0; 0;0) = 0. We also assume that her share of license
income, ®R, need not be the same as her share of sponsored research funds,
®S (indeed, for many respondents, ®S = 0). Because the Bayh-Dole Act
speci¯cally encourages universities to collaborate with commercial concerns
to promote the utilization of inventions arising from federal funding, and
TTOs are charged with this mission, she gets utility simply from executing
a license, UT(0; 0; 1) >0. Finally, her utility cost of searching for a licensee
is VT` >0, so that searching is not optimal at any stage unless it generates,
in expectation, su±cient additional utility (otherwise sheshelves the poten-
tial invention). Her expected utility from executing a licensecontract (R; S)
at stage j =C;L is thus
EUTj(®RR;®SS) = pj(S;Q)UT(®RR; ®SS; 1) +
[1¡pj(S;Q)]UT(0;®SS;1) ¡VT`. (1)
Consider the contracting problem at stage j = C;L, assuming that the
TTOdirector has decided to search for a licensee. A ¯rm accepts a contract
(R;S) only if its expected pro¯t under that contract is nonnegative, where
its expected pro¯t at stage j = C; L is
E¦j(R;S) =pj(S;Q)(¦ ¡R) ¡S ¡K. (2)
The TTO director's problem at stage j is to choose a contract (R; S) that
maximizes her expected utility subject to the licensee's participation (non-
negative expected pro¯t) constraint,
max
R¸0;S¸0
EUTj(®RR; ®SS) s:t: E¦j(R;S) ¸0. (3)
7We denote the solution values for this problem by (R¤
j;S¤
j). The solution is
(R¤
j, S¤
j) =(0; 0) when expected pro¯t is negative even if thelicense is given
to the ¯rm at no cost, or E¦j(R; S) <0 for all R ¸0 and S ¸0. However,
note that pj(0;Q) > K
¦ is a su±cient to guarantee E¦j(R;S) > 0 for some
R > 0 and S > 0, and thus that the solution to (3) has R¤
j > 0, S¤
j > 0, or
both.
Because the TTO director gets utility from simply executing a license
contract, it is possible that she would search for a licensee even if it re-
sulted in no licenseincomeorsponsored research funds for her, EUTj(0; 0) =
UT(0; 0; 1)¡VT` >0. However, in general, she does not search for a licensee




The solution to this licensing problem and the comparative statics results
for an interior solution are of interest.
Theorem 1 If pj(0;Q) > K
¦, then at the solution (R¤
j;S¤
j) to (3), a li-
censee's participation constraint is binding, E¦j(R¤
j; S¤
j ) = 0, and either
R¤
j > 0, S¤
j > 0, or both. The participation constraint is also negatively
sloped at the maximum, whether it is interior or not. If, in addition,
the TTO director's participation constraint (4) holds at (R¤
j;S¤
j), then she
searches for a licensee and executes the contract. If the solution is interior,
then:




j and increase S¤
j; or leave them unchanged.
(ii) An increase in quality Q or pro¯t from a success ¦ and a decrease in
the cost of commercialization K must increase either R¤
j or S¤
j, or both.
Theseresultsfollow directly fromtheparticipation constraintsof the¯rm
and TTOdirector. If pj(0; Q) > K
¦, then expected pro¯t at (R;S) =(0;0) is





j > 0, or both can beexecuted. She will incur the disutility of searching
for the licensee to execute the license contract if EUTj(®RR¤
j;®SS¤
j) ¸ 0.
Moreover, becauseEUTj(®RR;®SS) isincreasing in R and S, but E¦j(R; S)
is decreasing in R and S, the optimal contract must have the licensee's
participation constraint binding at the maximum, E¦j(R¤
j; S¤
j) = 0. And
because her indi®erence curves (in expected utility) are negatively sloped,
this constraint must be downward sloping at the maximum, whether it is
interior or at either corner. Thus, parametric changes such as changes in Q,
¦; and K that increaseE¦j(R;S) result in an outward shift of theconstraint
8from the point (R¤
j;S¤
j), so either R¤
j,or S¤
j , or both, must increase at the
new maximum on thenew constraint. Whilechangesin her sharesa®ect the
TTO director's expected utility, they do not shift the ¯rm's participation
constraint, so that eitherR¤
j and S¤
j remain unchanged, oronemust decrease
if the other increases. Which of these occurs depends on the e®ect of the
shares on the TTO director's marginal rate of substitution of royalties for
sponsored research funds. Forexample, as we show in the appendix, if TTO
utility isadditively separable, then an increasein hershareof licenserevenue
increases S¤
j and decreases R¤
j, while increase in her share of sponsored
research funds increases R¤
j and decreases S¤
j.
Theorem 2 Assume the TTO director does not receive ashare of sponsored









j; 0) =0, then the solution to (3) necessarily has S¤
j >0.
Again suppose pj(0; Q) > K
¦, so a licensee can be found if the TTO
searches. The contract (R0
j; 0) is the one that chooses the maximum license
revenue consistent with non-negative expected pro¯t. This contract cannot
be optimal if the marginal impact of the ¯rst dollar in sponsored research





j). Thus, the TTO may execute a contract that contains sponsored
research, even if she receives none of these funds. The reason is that she
recognizes that these funds can assist the inventor in the continued e®ort
to develop the invention for commercialization in a way that substantially
enhances the probability of success, and hence her expected utility from
license revenue.
2.2 The Inventor's Problem
We assume that the inventor is an expected utility maximizer with utility
function from disclosing an invention UI(yI; fI; `), where yI is his license
income, fI is his sponsored research funds. Again, we treat license income
di®erently from sponsored research funds, and we also assume that the in-
ventor's share of license income, ¯R, need not be the same as his share of
sponsored research funds, ¯S. The inventor's utility cost of disclosure is
VId > 0, so his expected utility from disclosing an invention at the lab-scale
prototype stageforwhich theTTO can ¯nd a licensee at thecontract (R; S)
is
EUIL(¯RR; ¯SS) = pL(S;Q)UI(¯RR; ¯SS;1) +
[1 ¡pL(S;Q)]UI(0;¯SS; 1) ¡VId. (5)
9If the inventor does not disclose, he receives the utility from his next best




and otherwise he automatically turns to the next best research project.
At theproof of concept stage, hisdecision ismorecomplex. If hediscloses
at that stage, his expected utility is
EUIC(¯RR; ¯SS) = pC(S;Q)UI(¯RR;¯SS; 1)
[1 ¡pC(S;Q)]UI(0;¯SS; 1) ¡VId. (7)
If he continues to the prototype stage, his expected utility discounted back
to the proof of concept stage is ±maxfEUIL(¯RR¤
L;¯SS¤
L); UIag, where ± 2







This plus the results in Theorem 1 immediately lead to the following.
Theorem 3 The subgame perfect equilibria of the game between the inven-
tor and TTO director can be characterized as follows:
(i) If pC(0;Q) > K
¦, EUTC(®RR¤
C;®SS¤





L)];UIag, then the inventor discloses at the proof of
concept stage and the TTO director searches for a licensee and executes a
license contract.
(ii) If pL(0;Q) > K
¦, EUTL(®RR¤
L; ®SS¤





C);UIag, then the inventor discloses at the lab-scale
prototype stage and the TTO director searches for a licensee and executes a
license contract.
(iii) Otherwise, the inventor immediately switches to his best alternative
research project and does not disclose the invention.
The higher is the inventor's utility from alternative research or his dis-
count rate (i.e., the lower is ±), the more likely it is that he will disclose an
invention at the proof of concept stage, if at all. However, higher faculty
quality, license income, or sponsored research increase expected utility in
both stages, and so have ambiguous e®ects on the stage of disclosure. No-
tice that even if pj(0; Q) > K
¦ and EUTj(®RR¤
j; ®SS¤
j) ¸ 0 for j = C;L,
so that the inventor knows the TTO is willing and able to execute a li-
cense, he may not disclose. He will not disclose at all if the utility from
10his next best alternative, which includes the value of immediate publication






An important implication of this result is that, while the inventor and
TTO are both agents of the administration, in the subgame between the
inventorand TTO, theTTOis an agent of theinventor. Given theinventor's
rateof timepreferenceand thesharesset by theadministration, hisexpected
utility in each stage is determined by the terms of the contract executed by
the TTO. Unless theTTO executes a licensethat is su±ciently attractiveto
the inventor, he will never disclose an invention to her, but instead simply
publish his research and move on to his next research project, in which
case the TTO has nothing to license. Our model therefore implies that the
TTO is a \dual" agent whose actions are in°uenced by the decisions of the
administration and the inventors, a relationship that we test in Section 3.
2.3 The Administration's Problem
The administration selects the contract terms for both the TTO and inven-
tor, which in this model is represented by the shares of license income and
sponsored research that the TTO and inventor receive. From our survey,
it is clear that these shares are set as a part of overall university policy
on intellectual property and are rarely changed.7 We shall therefore take
them as given and abstract from the details of theadministration'sproblem.
However, we do assume that the administration's utility also depends on li-
cense income, sponsored research funds, and whether a license is executed.
We also assume it maximizes expected utility, subject to the participation
constraints of the TTO and inventor. Therefore, because it receives license
revenue (1 ¡®R ¡¯R)R¤
j and sponsored research funds (1 ¡®R ¡¯R)S¤
j
from a successful license executed at stage j, its expected utility is strictly
decreasing in thesharesof licenserevenue and sponsored research fundspaid
to the TTO and inventor.
Because the shares do not vary by stage of development or invention,
either the TTO or the inventor, or both, are likely to earn rents on some
inventions. For example, if R and S are \normal" goods with respect to
TTO's expected utility, then license revenue and sponsored research funds
should both be greater if the contract is executed at thelab-scale prototype
7For many universities in the sample, income shares were set by their Board of Trustees
as early as the 1970s. Notable exceptions include the University of California system,
which altered the shares in the 1990s when the system was changed from one centralized
o±ce to a combination of a central o±ce and campus o±ces.





Thus, if the administration sets the shares so that the TTO's participation
binds for inventions disclosed at the lab-scale prototype stage, then she has
no incentive to try to license an invention disclosed at the proof of concept
stage, and so the inventor would not disclose an invention at that stage.
Alternatively, if the administration sets the shares so that her participation
constraint binds for inventions disclosed at the proof of concept stage, then
she earns rents on inventions disclosed at the lab-scale prototype stage.
Finally, it is interesting to note that we can obtain some testable im-
plications about the administration's choice of the inventor's shares simply
by examining his participation constraint. Recall that an increase in qual-
ity increases a licensee's expected pro¯t, and thus the license revenue and
sponsored research funds in a contract executed at either stage, R¤
j and S¤
j.
An increase in quality therefore increases the inventor's expected utility for
given shares¯R or¯S, and thus relaxes both of hisparticipation constraints.
Because thelicense revenueand sponsored research funds contracted by the
TTO do not depend on the inventor's shares, an increase in quality allows
the administration to reduce the inventor's shares (and thereby increase its
own shares) without violating his participation constraints. An increase
in the value of a successful invention ¦ similarly allows an increase in the
administration's shares at the expense of the inventor.
3 Empirical Tests of the Dual Agency Model
We have modeled university disclosure and licensing as a dual agency prob-
lem in which theTTO is an agent for both the administration and inventor.
This modeling choice seemed appropriate for several reasons. Oneis the ob-
vious point that while the university owns all intellectual property resulting
from patentableresearch, it is theTTOsthat are central to the operation of
university-industry technology transfer. The more subtle point comes from
our conversationswith TTO directors in the process of designing oursurvey.
These directors uniformly expressed the view that their job was to do the
best they could in terms of implementing Bayh-Dole, given the constraints
placed on them by their administration and the nature of inventions dis-
closed by their faculty (i.e., \the best we can do with the s**t we get to
work with"). The model presented in Section 2 formalizes this relationship,
allowing usto examinethe implicationsforTTO behavior in termsof license
objectives, licenses executed, the stage of development at which inventions
are disclosed, as well as the e®ects of faculty quality on the process.
12In this section, we test the model's implication that a TTO's objectives
in executing a license must take into account the interests of their two prin-
cipals, the administration and faculty. To test this hypothesis, we exploit
survey evidence on TTO views of the importanceof di®erent contract terms
and outcomes, from theirown perspective, as well astheir perceptionsof the
importance of contract terms to their administration and faculty. We asked
respondents to indicate the importance to them of a set of objectives by
answering the question, \How important to you are the following measures
of success?". In our model, we focused on the three measures of success
or \objectives" that were the most important to respondents, that is: (1)
royalties/license fees generated, (2) sponsored research funds, and (3) num-
ber of licenses/options signed. For each measure, the TTO could indicate
\Not very important," \Moderately important" or \Extremely important."
Respondents were also given an opportunity to indicate that an outcome
was \Not applicable."8 We also asked respondents about their perceptions
of the importance the faculty and administration attach to these objectives.
We asked \In your experience, how important do the following measures of
success seem to be to the faculty you have worked with?," and \In your
experience, how important do each of the following seem to be to your ad-
ministration?" Each question was followed by the objectives noted above.
It is important to note that in asking these questions, our goal was not to
determine theactual importancethat the administration and faculty attach
to these objectives, but rather to characterize TTOperceptions of their im-
portance.9 This allows us to examine empirically the probability that the
TTO will consider an objective important as a function of the perceived
importance to her administration and faculty. In Section 3.1 we present an
econometric model that allows us to make such inferences.
3.1 Econometric Model
We consider the importance the TTO of university i (i =1;:::; n) assigns to
objective j (j = 1;:::3), IMPORT
j
i , to bedetermined by a set of observable
characteristics and a random, unobservabledisturbance. We do not observe
IMPORT
j
i , instead we observe the categorical values the TTO is willing
to assign to the importance of each objective. For ease of estimation, and
without loss of generality, we assign the numerical scores TTO
j
i = 1, 2
8\Not applicable" responses are dropped from the econometric analysis.
9Hence our purpose is quite di®erent from the industrial psychology literature which
examines agreement among workers and supervisorsconcerning perceptions of each other's
performance (see, for example, Atwater et al. (1998)).
13and 3 to the categories \Not very important," \Moderately important" and
\Extremely important," respectively. The method of estimation is ordered
probit for all objectives except for royalties. Only one TTO responded that
royalties were not very important hence inclusion of that valuation as a
separate class would not be statistically meaningful. For royalties we use
a bivariate probit model to di®erentiate \extremely important" from other
valuations.
The determinants of IMPORT
j
i are measures of the TTO's perceptions
of the importancetheir faculty and administration attach to objective j, the
types of inventions produced by the faculty, characteristics of the university





i are the ordinal valuations the TTO at university





i we assign the same values 1, 2 or 3 as we did for




i would support our
view that the disclosure and licensing problem is one of dual agency, with
negative or insigni¯cant coe±cients rejecting the model.
We expect the importancethe TTOassigns to di®erent measures of suc-
cess to also be a function of the nature of inventions disclosed to her. For
example, it is di±cult to specify royalty income based on sales (i.e., run-
ning royalties) for very early stage technologies since the nature of the ¯nal
product is often unknown, and it is di±cult to de¯ne a royalty schedule for
a good whose ¯nal nature is di®use. If a large proportion of the disclosures
to the TTO are early stage inventions, it is conceivable that she will, all
else equal, consider royalties as less important in determining her success
than will a TTO with primarily late stage disclosures. Ideally, we would
include as measures of the nature of inventions the stage of development of
disclosures to the TTO. Unfortunately, wedo not have information on stage
of development for all disclosures. In our survey we asked the percentage of
licensed disclosures that were in various stages of development at thetime a
licensewas negotiated: \What percentage of the invention disclosures which
havebeen licensed in the last ¯veyears were in thefollowing stages of devel-
opment at the time the license was negotiated?" As regressors, we use the
percentage of licenses that were only \Proof of concept but no prototype"
(PROOFi) and the percentage where there was a \Prototype available but
only lab scale (further development needed)" (PTY PEi). An invention in
10An alternative would be to form a set of indicator variables. However, since the
dependent variable consists of the same set of ordinal measures ("not very important,"
etc.) we feel it more appropriate to measure facultyand central administrationimportance
via the ordinal rankings.
14either state PROOFi or PTY PEi is considered to be in an early stage of
development and PROOFi is earlier than PTY PEi We experimented with
using the sum of these two measures rather than introducing them sepa-
rately, but the results were not as revealing.
We include a measure of faculty quality, QUALi,because as we assume
in our theoretical model, we expect quality to a®ect the probability that
inventions will be commercially successful, and hence the stage at which in-
ventions are disclosed and the equilibrium contract terms. For our measure
of quality we use the 1993 National Research Council's (NRC 1995) survey
results regarding theacademic quality of Ph.D. granting departments. This
measureis°awed sinceit considersonly thequality of Ph.D. granting depart-
ments. However, apart from medical schools, it is plausible that substantial
research programs have di±culty existing in the sciences and engineering
without Ph.D. students. We usea weighted average of the department qual-
ity scores where the weights are faculty size. The quality scores range from
0 to 5 where 5 indicates a distinguished department.
Thursby and Kemp (2002) and Thursby and Thursby (2002) present ev-
idence that university licensing outcomes and e±ciencies are in°uenced by
the presenceof a medical school. Whether this presencein°uences outcomes
via di®erent preferences of medical school faculty versus other faculty or via
generally di®erent characteristics of medical school inventions versus other
inventions is not clear. In addition, our measure of quality does not include
medical school faculty except in those cases where a faculty member has an
appointment in a Ph.D. granting department. Hencewealso includean indi-
cator variable for thepresenceorabsence of a medical school (MEDSCHLi
= 1 if there is a medical school, 0 otherwise) .
Wealso includetheratio of industry research support to federal research
support (INDFEDi). Greater industry support relative to federal support
can suggest a greater applied rather than basic research orientation of the
faculty. Further, the Bayh-Dole Act of 1980, which grants to universities
rights of ownership of innovations developed with federal research support,
requires that commercializable inventions be disclosed to the university's
TTO and that universities retain ownership of those innovations. Universi-
ties with large federal research support are expected to consider compliance
with Bayh-Dole as an important measure of their success. We use the aver-
ages of industry and federal support over 1992-97.
We consider a single measure of general university characteristics. We
include whether a university is public or private (PUBLICi = 1 if uni-
versity i is public, 0 otherwise) since public universities tend to be more
restricted than are theprivate universities in certain of their licensing activ-
15ities. We asked respondents \Are there corporate or legal nuances speci¯c
to your TTO (e.g. state laws, charters, federal grant or loan covenants,
state or university mandates, etc.) which a®ect the way in which you try to
commercialize university inventions?" More than 47 percent of the public
universities indicated that thiswastruewhereasonly 30.4 percent of private
universities answered yes. To the extent that there are di®erent restrictions
on the TTO, this may manifest itself in di®erent objectives of the TTO.
Finally, we consider that the background and experience of personnel
in the TTO can in°uence the importance they attach to objectives. The
measure we choose is the number of years of industry experience of the
TTO director (INDEXPi).
Summary statistics are found in Table 1.
Unfortunately, as will be discussed in the ¯nal section, we have limited
and incomplete direct measures of the return to the TTO for good perfor-
mance in obtaining objectives (that is, measures of ®S and ®R).
3.2 Results
Coe±cient estimates and their levels of signi¯cance are in Table 2. The co-




i , the TTO's
perceptions of the importance the faculty and central administration place
on objective j as a measure of success. In each regression these coe±cients
are positive and all are signi¯cantly di®erent from zero except for FAC
j
i
in the equation for licenses executed. This lends support for our view that
TTOs measureherown successbased on herperceptionsof both faculty and
administration objectives. Moreover, the more important the TTO thinks
an objective is to the two principals, the more she pays attention to the
objective as a measure of success.
We can further characterize the TTO response to faculty and adminis-
tration objectives, as well as to the Bayh-Dole charge, by a series of exper-
iments. We begin by calculating the probability that the TTO will report
her own measure of valuation as not very important, moderately important
or extremely important (TTO
j
i = 1; 2;3, respectively) conditional on the
faculty and administration agreeing on the importance of the the objec-







i = l) for k and l = 1;2;3. This is done for each university and
the average estimated probability is reported in the top section of Table 3.





i = l 6= ADMIN
j
i = m) for k = 1;2; 3 and l
and m equal to 1 or 3. Results are in the second section of Table 3.
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or 3, there is a high probability that the TTOwill disagree and value spon-





i theTTO will, with low probability, value sponsored re-
search asextremely important, but shewill bemorein°uenced by thefaculty
views than by those of the administration. This supports the result stated
in Proposition 2. Many of the TTOs in our sample receive a zero share of
sponsored research, yet one third of the licenses executed include sponsored
research. In the context of our model, this should occur when the TTO
realizes that sponsored research for the inventor improves the probability
the invention will be successfully commercialized.
When faculty and administration agree that royalties are either ex-
tremely or not very important, there is a very high probability that the
TTO will agree. When these groups agree but value royalties only moder-
ately important, there is still a high probability that the TTO will value
royalties as extremely important. When the TTO believes the faculty and
administration disagree, she is closer to the administration, though there is
still a substantial probability that she will agree with the faculty.
In discussions with TTO professionals it is clear that many consider
the signing of a license agreement as a compliance measure for the Bayh-
Dole Act. This is manifested, we believe, in the estimated probabilities
when faculty and administration agree and do not agree on the importance
of licenses executed. When there is agreement that licenses executed are
not very or moderately important, there is a greater probability that the
TTO will value licenses more highly. When the faculty and administration
agree that licenses executed are extremely important, the TTO will almost
certainly agree. When there is disagreement, there is a very low probability
that the TTO will value licenses executed as not very important.
4 Quality and Stage of Development
In our survey we asked respondents to indicate the fraction of licensed in-
ventions that were in di®erent stages of development. The majority of in-
ventions were in early stages of development; on average 47% of licensed
inventions were no more than a proof of concept (PROOFi) and 37% have
only a prototype available (PTYPEi). Of greater interest for our purposes
is the variability we observe across universities. For example, 17 of 52 uni-
versities report more than 60% of licensed inventions are in the proof stage
17and 15 report more than 60% arein the prototype stage. On theotherhand
9 report that 10% or fewer are in the proof stage and 11 report that for the
prototype stage. Are these di®erences merely chance outcomes of research?
Is this simply the result of di®erent sciences with di®erent commercial po-
tential and the\black box" probability of success? Our theory suggeststhat
the answer is no. Recall that a necessary condition for an invention to be
licensed at stage j is pj(0;Q) > K
¦ for j = C;L: Faculty quality a®ects the
stageat which an invention can belicensed and therefore thestage at which
it might be disclosed. Thus, while comparative static results on quality are
ambiguousin general, we expect that if higher quality faculty disclose at all,
they will be more likely to disclose at the proof of concept stage than the
lab-scale prototype stage. This is surely the case if themarginal e®ect of an
increase in quality is higher at the proof of concept stage than the lab-scale
prototype stage.
In this section we propose and estimate an econometric model that re-
lates the stage of development when a license is executed to observable
characteristics of universities. We concentrate on the stages of develop-
ment, PROOFi and PTY PEi, and relate theseto the sources of inventions,
the academicquality of the institution, and measuresof success of the TTO.
Again, aswenoted above, we haveinformation on stageof development only
for disclosures that arelicensed rather than for all disclosures. However, the
two should be highly correlated.
To measure the sources of inventions we include the fraction of licenses
executed that come from engineering, ENGFRACi, medicine and nursing,
MEDFRACi, and science, SCIFRACi. As a further measure of focus
of research at the institution we also include the ratio of industry research
support tofederal research support, INDFEDi. Asfederal research support
tendsto bemorebasic, weexpect a smaller ratio tobeassociated with earlier
stage inventions. Our measure of quality of the institution, QUALi, is the
one used above in modeling theimportance of di®erent measures of success.
We include several measures of the success of the TTO in executing
licenses that generate income. The ¯rst is the net royalty income received
by the o±ce in the year of our survey (1997), NETINCi. This measure of
the \wealth" of the o±cecan in°uencestage of development by a®ecting the
TTO's marginal utility for another license generating income, and thus less
desireto license early. Richer o±ces, therefore, might discourage disclosures
in early stages of development. The second measure of success is the ratio
of net income to the number of licenses generating royalties, INCLICi.
Faculty are expected to be more willing to disclose, which might also a®ect
the timing of disclosure, if they believe the TTO is likely to be successful in
18generating royalty income.
Results arein Table4. In both equationsthe coe±cient of QUALi is sig-
ni¯cantly di®erent from zero at the 5% level. Further, higher quality faculty
are more likely to disclose in the earliest stage PROOFi rather than in the
later (though still early) stage PTY PEi. In the context of our theory, this
supports the view that the marginal impact of quality on the probability of
successis highest at theproof of concept stage. Although we did not include
quality as an argument in the utility from the inventor's next best alterna-
tive or rate of time preference, natural assumptions in this regard would
lead one to expect a positive relationship between quality and disclosure at
proof of concept stage.11
ENGFRACi and MEDFRACi are each signi¯cant and positive in the
PROOFi equation and signi¯cant and negative in the PTYPEi equation.
This would appear to be counterintuitive for ENGFRACi, as engineering
tends to be an applied science. One reason for earlier stages of disclosure
and license for engineering might be di®erences in attitudes towards com-
mercialization. If engineering faculty are more willing to be a participant
in licensing, then they may well be more willing to disclose early. In ad-
dition, as engineering is more applied, it may well be the case that early
stage inventions in engineering have, in general, more obvious commercial
potential.
NETINCi is signi¯cant and negative in the PROOFi equation and in-
signi¯cant in the PTYPEi equation. As noted above, webelievethisfollows
from \wealthier" o±ces discouraging early stage inventions. As predicted
INCLICi a®ects stage of invention disclosure and license; more successful
o±ces encourage earlier stages.
5 Inventor Share
Finally, recall ourmodel predictsan inverserelation between inventorquality
and the shares of license income and sponsored research that the adminis-
tration will set for theinventor. In our survey weasked forthepercentageof
royalty income accruing to the TTO and the faculty. Unfortunately, shares
of income are not completely revealing of the incentive structure at a uni-
versity. For example, it is the case that salary increases for both the TTO
11For example, one would expect higher quality inventors to place more utility on their
next best alternative higher and on publishing sooner, which would imply a higher rate of
time preference as well. Their disclosure cost also might be higher. Each of these tends
to imply earlier disclosure, if it occurs at all.
19and the faculty can be in°uenced by disclosure and licensing success. It
is certainly the case that there are additional incentives beyond shares of
royalty income for at least the TTO as almost 70% report that they receive
no share of royalty income. In all cases faculty shares, while variable, are
greater than zero. We test the above implication of our model using re-
ported faculty shares of royalty income with thecaveat that such shares are
an imperfect measure of the incentives provided to faculty by the admin-
istration. We regress the faculty share on our measure of faculty quality,
QUALi, as well as measures of the sources of inventions, ENGFRACi,
MEDFRACi, and SCIFRACi and our measure of theuniversities focus of
research, INDFEDi. Results are in Table 5. As predicted by our model,
faculty shares are negatively related to quality.
6 Conclusion
TTOs have primary responsibility for the university licensing function, and,
in particular, implementing provisions of the Bayh-Dole Act. These o±ces
are responsible for facilitating faculty disclosure of inventions, evaluating
those inventions disclosed, as well as ¯nding licensees and executing con-
tracts on behalf of the central administration for the university (which owns
the inventions). Despite their importance, little research has focused on the
balancing act played by the TTOand how it a®ectsthe natureof inventions
disclosed and theoutcomes of the process. In this paper, we address this is-
suedirectly by modeling the technology transfer process as a game in which
the central administration is the principal and both the TTO and faculty
are agents, but the TTO is also an agent for the faculty.
Our modeling choice re°ects conversations with numerous directors of
TTOs. These discussions revealed a major frustration of their job is induc-
ing high quality disclosures (hence the subtitle of our paper). The directors
wetalked with believe that someof thebest inventionsmay not bedisclosed
because the most productive faculty are less likely to want to take the time
to discloseinventions, much less work on furtherdevelopment. They also be-
lievethat many of theinventions disclosed to them areof questionablevalue.
This suggests that the nature of inventions disclosed in U.S. universities is
related to faculty quality, but perhaps in unanticipated ways. The analysis
also yields predictions forcontract terms as well as thestage of development
of inventions disclosed. In equilibrium, because of the e®ect of quality on
the probability of success, the TTO may include sponsored research in a
licenseeven if shereceives a zero share of these funds. Whether theinventor
20discloses, and at what stage, is a function of the equilibrium license income
and sponsored research, the inventor's rate of time preference, and quality.
Empirical tests of the theory provide support for the dual agency view
that TTOs measure their own success based on their perceptions of both
faculty and central administration objectives. Moreover, themoreimportant
the TTO thinks an objective is to the two principals, the more she pays
attention to the objective as a measure of success. With respect to the stage
of development, we ¯nd that universities with higher quality faculty have
a higher proportion of disclosures licensed in the proof of concept stage,
as do universities with higher fractions of inventions from medicine and
nursing or from engineering. We also ¯nd that universities with greater
net income have a smaller proportion of disclosures licensed in the proof
of concept stage, although more successful TTOs with greater income per
licenseencouragedisclosureat the proof of concept stage. Finally, the share
of royalty income allotted to inventors is lower for universities with higher
quality faculty.
We think it is worth noting that the theoretical results presented here
are also consistent with the empirical results presented in an earlier paper
(Thursby et al., 2001), wherein we ¯nd a positive relationship between fac-
ulty quality and royalty payments and a negative relationship between the
frequency of sponsored research agreements in a license and faculty quality.
Although we have found substantial support for our assertion that uni-
versity TTOs act as an agent for both the administration and the faculty,
we acknowledge that there are still many unanswered questions about the
process of technology transfer from the academy to industry. For example,
the total compensation packages for both inventors and TTO directors in-
clude more than just their shares of royalties and sponsored research funds.
A morecompletemodeling of thesecompensation packages and their choices
would be interesting. For example, the inverse relationship between faculty
quality and their share of license income is, one supposes, closely linked to
the (expected) direct relationship between faculty quality and their salary.
Similarly, many universities in our survey noted that faculty had substan-
tial discretion in determining the allocation of the sponsored research funds
associated with their licenses. Clearly universities have at their disposal,
and frequently employ, a variety of compensation schemes for inventors and
TTO directors. Unfortunately, lack of data prevents us from examining the
empirical relationship between the \total" compensation packages and the
nature of license contracts or the stage of development at which disclosure
occurs.
Even in the context of this model, the university administration's prob-
21lem is also quiteinteresting from another perspective. Fora given invention,
it is straightforward to solvethisproblem. Onesimply determines thesmall-
est sharesfor the TTOand inventor that induce them to discloseand license
this invention at the concept stage (assuming this is feasible), and then the
smallest shares that induce them to disclose and license this invention at
the prototype stage. The administration then simply compares its expected
utility at the concept stage with its discounted expected utility at the pro-
totype stage, and chooses the shares to induce disclosure and licensing at
the appropriate stage. However, the solution is less evident when taking
into account the fact that shares cannot be chosen for each individual in-
vention, but instead must be chosen for all inventions disclosed over some
period of time. The solution to this problem is well beyond the scope of this
paper, but is clearly an important topic for future research because it has a
substantial impact on the university-industry technology transfer process.
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8 Appendix A: Survey Design
Questionnaires were sent to the top 135 universities in terms of licensing
revenue according to the 1996 AUTM Survey, and responses were received
from 62 universities. In examining the characteristics of non-respondents
compared to respondents, we ¯nd that they di®er primarily in their volume
of licensing activity, with non-respondents being less active than respon-
dents. While this suggests that our sample is not fully representative of the
population of universities, it is important to note that the original intent
was not to obtain a random sample, but rather to characterize the bulk of
licensing activity at U.S. universities. In selecting the 135 universities to
sample, we therefore choose the top 135 in terms of licensing activity, and
having respondents skewed toward more active o±ces ¯ts with the original
design.
For more detail on survey design see Jensen and Thursby (2001) and
Thursby et al. (2002). For the survey questions relevant for this paper
there are two important, potential problems. First, TTOs do not maintain
¯les on thefraction of inventionsin di®erent stagesof development. As such,
in answering our question about stage of development answers arebased on
the respondents perceptions, thus it is expected that there is a lot of noise
in the data. However, there is no reason to suspect that answers are biased
given that our stage of development terminology is standard across TTOs.
Second, our objectives questions are based on a semantic scale and respon-
23dents may perceive the same environment but use the scale di®erently. To
minimize error of this type, we based our scale on research results from the
literature on optimal rating scales. As discussed by Krosnick and Fabrigar
(1997), research on the reliability of rating scales suggests people can dis-
tinguish among and have consistent interpretations of the four point scale,
\extremely important," \moderately important," \not very important," and
\not applicable."
9 Appendix B
9.1 Proof of Theorem 1
If pj(0; Q) > K






















for all R ¸ 0 and S ¸ 0, it follows that the solution to (5) must have
the licensee's participation constraint binding E¦j(R¤
j;S¤
j) = 0, and either
R¤
j > 0, S¤
j >0, or both. The condition E¦j(R;S) =0 implicitly de¯nes R
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Let Fj(R;S; ¸) =EUTj(R;S)+¸E¦j(R; S) where¸ is a Lagrange mul-
tiplier. If an interior solution with R¤
j > 0 and S¤
j > 0 exists, then the ¯rst

































































Using thestandard Kuhn-Tucker approach, the¯rst ordernecessary con-






























where the last condition implies R0
j is de¯ned by pj(0;Q)(¦¡R0
j) = K, and
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@R < 0. Therefore, because
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@S < 0, whence Á0
j(0) <0.
Similarly, the standard Kuhn-Tucker necessary conditions for a maxi-






























where the last condition implies S0
j is de¯ned by pj(S0
j; Q)¦ = K, and









@R > 0 and
25@E¦j
@R < 0. Therefore, because
@EUTj(0;S0
j)




@S <0, whence Á0
j(S0
j) < 0.
Thesecond ordersu±cient condition fora maximum is negativede¯nite-
ness of the bordered Hessian matrix Hj for all R ¸ 0 and S ¸ 0, or detHj >
0, which we assume. Assuming an interior solution, R¤
j > 0 and S¤
j > 0,


























































































































@R@®S ¸ 0 and
@2Fj
@S@®S · 0: In general, these conditions need not hold,
but they do for certain classes of utility functions. For example, they hold
if TTO utility is additively separable, in which case
@R¤
j












































@R@®R ] areambiguous, in gen-






@®R. However, detHj(R; ®R) <0 and detHj(S;®R) >
0 whenever TTO utility is additively separable, in which case
@S¤
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@R@S ] are ambiguous, in
general. However, if
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@S < 0 at the maximum. Hence, any
parametric change that increases E¦j(R; S) in general implies that now
E¦j(R¤
j; S¤
j) > 0. Therefore, either R¤
j, or S¤
j, or both, must increase to
restore equality in the constraint. That is, if
@E¦j(R;S)






@x > 0, or both. Graphically, the constraint E¦j(R;S) = 0







< 0 because E¦j(R; S) is assumed to be decreasing in R and S
at the maximum. Thus, any parametric change that increases E¦j(R; S)





j , or both, must increase at the new maximum on the new


















9.2 Proof of Theorem 2
As noted in the proof of Theorem 1, the ¯rst order necessary conditions
















































. In this case the corner solution (R0
j;0) on the zero
expected pro¯t constraint cannot be a maximum, which with pj(0; Q) > K
¦
implies the optimal contract must have S¤
j > 0.
28Variable # Obs. Mean Std. Dev.
Fraction public universities PUBLIC 62 0.63
Fraction with medical school MEDSCHUL 62 0.60
Faculty quality QUAL 60 3.14 0.83
Faculty income shares 62 38.51 12.69
Fraction proof of concept PROOF 52 44.16 28.14
Fraction prototype available PTYPE 52 37.19 27.66
Industry to federal expenditures INDEXP 54 11.22 9.68
Industrial experience INDFED 61 0.14 0.09
Income per license (millions of dollars) INCLIC 57 0.10 0.19
Net income (millions of dollars) NETINC 61 4.21 8.57
Fraction of licenses from School of Science SCIFRAC 58 21.90 18.37
Fraction of licenses from School of Engineering ENGFRAC 58 28.69 22.82
Fraction of licenses from Medical Schools MEDFRAC 58 33.08 33.69
TTO importance
Royalties 61 2.69 0.50
Sponsored research 61 2.38 0.55
Licenses executed 62 2.66 0.54
Faculty importance
Royalties 61 2.18 0.70
Sponsored research 61 2.72 0.52
Licenses executed 61 2.31 0.76
Administration importance
Royalties 61 2.43 0.62
Sponsored research 57 1.75 0.66
Licenses executed 61 2.03 0.68




FAC     -- Spon.Research 1.650 ***
ADMIN -- Spon. Research 0.957 ***
FAC     -- Royalties 3.899 **
 ADMIN -- Royalties 7.002 **
FAC      -- Licenses 0.538
ADMIN  -- Licenses 1.158 ***
PROOF -0.027 *** -0.198 ** 0.005
PTYPE -0.023 ** -0.081 * 0.008
MEDSCHL -0.003 5.468 ** -0.155
QUAL 0.068 2.579 * 0.606 *
INDFED -0.766 76.499 * -1.666
PUBLIC 0.151 -0.311 0.668
INDEXP -0.008 0.014 -0.016
Psuedo R-Square 0.313 0.726 0.257
Number of observations 42 42 38
Chi-square statistic for overall fit 27.26 *** 17.88 ** 19.92 **
*** Significant at 1% level
**  Significant at 5% level
*   Significant at 10% level
+ Bivariate probit model as explained in text.
Table 2. Ordered Probit Results on TTO Measures of SuccessSponsored Research Royalties Licenses Executed
TTO=1 TTO=2 TTO=3 TTO=1 TTO=2 TTO=3 TTO=1 TTO=2 TTO=3
When Faculty and Central Administration AGREE
FAC=ADMIN=1 0.984 0.016 0.000 NA 0.961 0.039 0.282 0.591 0.127
FAC=ADMIN=2 0.503 0.468 0.029 NA 0.666 0.334 0.021 0.341 0.638
FAC=ADMIN=3 0.009 0.380 0.611 NA 0.045 0.955 0.000 0.034 0.965
When Faculty and Central Administration DISAGREE
FAC=1, ADMIN=3 0.720 0.265 0.007 NA 0.379 0.621 0.005 0.181 0.813
FAC=3, ADMIN=1 0.271 0.640 0.089 NA 0.821 0.179 0.066 0.508 0.426
NA: Bivariate probit model is used.
Table 3. Estimated Conditional ProbabilitiesProof Prototype
ENGFRAC 0.469 ** -0.440 *
SCIFRAC -0.171 -0.061
MEDFRAC 0.305 * -0.490 **
QUAL 12.651 ** -9.006 *
INDFED 16.478 -68.974
INCLIC 36.788 * -49.898 **
NETINC -0.594 ** -0.184
CONSTANT -20.903 113.708 ***
R-Square 0.211 0.273
Number of observations 47 46
F-statistic for overall fit 3.04 ** 3.49 *
*** Significant at 1% level
**  Significant at 5% level
*   Significant at 10% level







Number of observations 55
F statistic for overall fit 4.83 ***
*** Significant at 1% level
**  Significant at 5% level
*   Significant at 10% level
Table 5. Faculty Shares